auto_awesome
Want to know who else bid on this?
ProposalForge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Recipient
BioCanRx: Biotherapeutics For Cancer Treatment /BioCanRx: Biothérapies pour le traitement du cancerAmount
$38.0M
Program
SSF - Science & ResearchProvince
ONType
Contribution
Agreement Number
033-2024-2025-Q1-515281
Purpose
BioCanRx was established in 2015 as a federally-funded NCE to develop, manufacture, and clinically test new cancer immunotherapies.
BioCanRx: Biotherapeutics For Cancer Treatment /BioCanRx: Biothérapies pour le traitement du cancer × Innovation, Science and Economic Development Canada
2 grants totalling $76.0M
SSF - Science & Research
28 grants totalling $691.1M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Genome Canada / Génome Canada | $154.2M | SSF - Science & Research |
| Stem Cell Network | $48.5M | SSF - Science & Research |
| CANADIAN CENTRE FOR AGING & BRAIN HEALTH INNOVATION ADV INC. | $39.2M | SSF - Science & Research |
| MEOPAR Inc | $38.1M | SSF - Science & Research |
| MEOPAR Incorporated | $38.1M | SSF - Science & Research |